U.S. Stem Cell, Inc.
USRMDelisted- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001388319
U.S. Stem Cell, Inc. was delisted in 2026; its insiders filed their last Form 4 on Apr 29, 2022; 1 institution reported holding it in 13F filings for Q2 2026, worth $11 in total; no superinvestor held it.
Holders of 5% or more of USRM
Holders whose latest Schedule 13D or 13G filing reports 5% or more of U.S. Stem Cell, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of U.S. Stem Cell, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on U.S. Stem Cell, Inc., newest first.
No Schedule 13D or 13G filings on U.S. Stem Cell, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell U.S. Stem Cell, Inc. shares.
No Form 144 notices for U.S. Stem Cell, Inc. are on file.